Platelet‐Activating Factor Acetylhydrolase in Red Cell Membranes: Does Decreased Activity Impair Erythrocyte Deformability in Ischemic Stroke Patients?

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Stroke

• Publication date

  1993-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.24.1.14PMID 8418541
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activity of platelet‐activating factor acetylhydrolase exists in red cell membrane

  1992cited by this paper
• Participation of serum albumin and LDL-cholesterol in impaired blood cell-filterability affected by white blood cells in patients with cerebral thrombosis.

  1992cited by this paper
• Platelet‐activating factor acetylhydrolase activity in red blood cell‐stroma from patients with cerebral thrombosis

  1992cited by this paper
• Infarct Reduction by the Platelet Activating Factor Antagonist Apafant in Rats

  1992cited by this paper
• Hemorheological factors in cerebral ischemia.

  1991cited by this paper
• Novel Neutrophil Agonists: Oxidatively-Fragmented Phosphatidylcholines

  1991cited by this paper
• Platelet-activating factor acetylhydrolase in human erythrocytes.

  1991cited by this paper
• Platelet‐activating factor in stroke and brain injury

  1991cited by this paper
• Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.

  1991cited by this paper
• Quantitative analysis of human erythrocyte spectrin by sodium dodecyl sulfate-polyacrylamide gel electrophoresis using pancreatic trypsin inhibitor (Kunitz) as an internal standard.

  1991cited by this paper
• Impaired blood rheology: a risk factor after stroke?

  1991cited by this paper
• Membrane damage due to lipid oxidation.

  1991cited by this paper
• Platelet-activating factor acetylhydrolase activity in human tissues and blood cells

  1991cited by this paper
• Platelet-activating Factor

  1991cited by this paper
• Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators.

  1990cited by this paper
• Platelet-activating factor.

  1990cited by this paper
• Platelet-activating factor. A putative mediator in central nervous system injury?

  1990cited by this paper
• Oxidation-induced changes in microrheologic properties of the red blood cell membrane.

  1990cited by this paper
• An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.

  1989cited by this paper
• Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.

  1989cited by this paper
• Blood rheology in patients with transient ischemic attacks.

  1988cited by this paper
• Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease.

  1988cited by this paper
• Human plasma platelet-activating factor acetylhydrolase. Purification and properties.

  1987cited by this paper
• Pentoxifylline improves white cell rheology in claudicants

  1985cited by this paper
• Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats.

  1983cited by this paper
• Analysis of the hematocrit distribution in the mesenteric microcirculation.

  1982cited by this paper
• Capillary network geometry and red cell distribution in hamster cremaster muscle.

  1982cited by this paper
• Blood filtrability in cerebrovascular disorders, with special reference to erythrocyte deformability and ATP content.

  1981cited by this paper
• In vivo measurements of "apparent viscosity" and microvessel hematocrit in the mesentery of the cat.

  1980cited by this paper
• Blood filtrability in cerebrovascular disorders, with special reference to erythrocyte deformability and ATP content

  1980cited by this paper
• Microvascular hematocrit and red cell flow in resting and contracting striated muscle.

  1979cited by this paper
• Red Cell Deformability and Risk Factors in one Hundred Patients with Cerebrovascular Thrombosis

  1979cited by this paper
• A simple method for measuring erythrocyte deformability.

  1976cited by this paper
• RBC velocity profiles in arterioles and venules of the rabbit omentum.

  1975cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Diet-Dependent and Diet-Independent Hemorheological Alterations in Celiac Disease: A Case-Control Study

  2020cites this paper
• Osmotic deformability of erythrocytes at various shear stresses

  2015cites this paper
• Evaluation of lipoprotein-associated Phospholipase A2 in Healthy Chinese Han Adult Serum

  2014cites this paper
• Effect of Platelet Activating Factor-Acetyihydrolase on the Formation and Action of Minimally Oxidized Low Density Lipoprotein

  2013cites this paper
• Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: effect of long-term therapy with erythropoietin.

  2005cites this paper
• [Raman spectrum of nano-graphite synthesized by explosive detonation].

  2005cites this paper
• Cadmium-induced changes in cation-osmotic haemolysis in rats.

  2000cites this paper
• Platelet-activating factor acetylhydrolases in health and disease.

  2000cites this paper
• Phospholipase A(2)s and lipid peroxidation.

  2000cites this paper
• Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity.

  2000cites this paper
• Cation-osmotic haemolysis in stroke patients

  1999cites this paper
• Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers.

  1999cites this paper
• Age-dependent differences in cation-osmotic haemolysis in rats

  1999cites this paper
• Secretory PAF-acetylhydrolase of the rat hepatobiliary system: characterization and partial purification.

  1998cites this paper
• Secretory PAF-acetylhydrolase of the rat hepatobiliary system: characterization and partial purification.

  1998cites this paper
• Pathological Aspects of Platelet-Activating Factor (PAF)

  1997cites this paper
• Deficiency of plasma platelet‐activating factor acetylhydrolase: Roles of blood cells

  1996cites this paper
• Inflammatory reactions at the blood-endothelial interface in acute stroke.

  1996cites this paper
• Mammalian platelet-activating factor acetylhydrolases.

  1996cites this paper
• Platelet-activating factor acetylhydrolase activity in intestinal mucosa and plasma of patients with Crohn's disease.

  1996cites this paper
• The fate of platelet-activating factor: PAF acetylhydrolases from plasma and tissues

  1996cites this paper
• Metabolic processing of PAF

  1995cites this paper
• Platelet‐activating factor: a mediator for clinicians

  1995cites this paper
• Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.

  1995cites this paper
• Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes.

  1995cites this paper
• Density-associated changes in platelet-activating factor acetylhydrolase activity and membrane fluidity of human erythrocytes

  1994cites this paper